Fenfluramine as antiseizure medication for epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fenfluramine as antiseizure medication for epilepsy

Published:2021-02-09 Issue:8 Volume:63 Page:899-907
ISSN:0012-1622
Container-title:Developmental Medicine & Child Neurology
language:en
Short-container-title:Dev Med Child Neurol

Author:

Gogou Maria¹^ORCID,Cross J Helen¹²^ORCID

Affiliation:

1. Department of Neurology Great Ormond Street Hospital for Children NHS Trust LondonUK

2. Developmental Neurosciences University College London NIHR BRC Great Ormond Street Institute of Child Health London UK

Publisher

Wiley

Subject

Clinical Neurology,Developmental Neuroscience,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dmcn.14822

Reference54 articles.

1. Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning

2. Drug repositioning for psychiatric and neurological disorders through a network medicine approach

3. Filling the gap in CNS drug development: evaluation of the role of drug repurposing

4. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies

5. Brain Serotonin, Carbohydrate-Craving, Obesity and Depression

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Zebrafish-Based Platform for High-Throughput Epilepsy Modeling and Drug Screening in F0;International Journal of Molecular Sciences;2024-03-04

2. Drug repurposing for rare: progress and opportunities for the rare disease community;Frontiers in Medicine;2024-01-17

3. Drug repurposing for rare diseases;Progress in Molecular Biology and Translational Science;2024

4. Rare epilepsy treatment: What is on the gene‐code lottery list?;Developmental Medicine & Child Neurology;2023-09-27

5. Revisiting the concept of drug‐resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force;Epilepsia;2023-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3